United Kingdom · Biotechnology startup
United Kingdom · Chroma Therapeutics
Chroma Therapeutics is a biotechnology company located in Oxford/Abingdon, UK.
Funding reportedLast round: Series B
About Chroma Therapeutics
Chroma Therapeutics is a biotechnology company located in Oxford/Abingdon, UK.
The company focuses on discovering and developing novel small-molecule drugs aimed at treating cancer and inflammatory disorders. Their research emphasizes chromatin biology and cell accumulation approaches, targeting high-prevalence cancers and inflammation. One of their key products is Tosedostat®, an oral anti-cancer drug that is in late-stage development for leukemia and is being studied in multiple Phase 2 trials for acute myeloid leukemia (AML) and high-risk myelodysplastic syndrome (MDS). Chroma Therapeutics is also developing a pipeline of therapies for inflammation, utilizing its proprietary cell accumulation approach that targets the nucleus of cells. The company has established partnerships, including one with GlaxoSmithKline (GSK) since 2009, and maintains a strong network of academic collaborators.
What company datasets say Chroma Therapeutics raised
Funding, as reported
Founders and team
From Chroma Therapeutics's own website: 2 on the team.
- Jeffrey WalshChief Executive Officer
- Lisa McGrathChief People Officer
The company, in detail
What they build
Built with from their website
DocuSignAtlassianZoom MeetingsMimecastGoDaddy DomainsAmazon AWSWebflow HostingMicrosoft Exchange OnlineApple Business ManagerMicrosoft Exchange
+6 more
Microsoft 365OutlookMicrosoft 365 Apps & ServicesMicrosoft Email ProvidersGoDaddy HostingApple School Manager
- Sector
- Biotechnology
- Industry code
- NAICS 541714, SIC 8731
- Region
- England
- Revenue
- 780k a year, as listed
- Full record
- Every detail in the company directory
Biotechnology in United Kingdom
Startups like it
Is this your company?
Add your raise, your deck and your story, and put Chroma Therapeutics in front of investors. Or tell us what we have wrong.